BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nair VS, Gevaert O, Davidzon G, Plevritis SK, West R. NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer. 2014;83:189-196. [PMID: 24355259 DOI: 10.1016/j.lungcan.2013.11.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Yao F, Liu H, Li Z, Zhong C, Fang W. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells. Tumor Biol 2015;36:2049-57. [DOI: 10.1007/s13277-014-2812-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
2 Li W, Liu H, Cheng F, Li Y, Li S, Yan J. Artificial intelligence applications for oncological positron emission tomography imaging. Eur J Radiol 2021;134:109448. [PMID: 33307463 DOI: 10.1016/j.ejrad.2020.109448] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Vinod Prabhu V, Elangovan P, Niranjali Devaraj S, Sakthivel KM. Targeting NF-κB mediated cell signaling pathway and inflammatory mediators by 1,2-diazole in A549 cells in vitro. Biotechnol Rep (Amst) 2021;29:e00594. [PMID: 33598414 DOI: 10.1016/j.btre.2021.e00594] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liang J, Lu F, Li B, Liu L, Zeng G, Zhou Q, Chen L. IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function. Cell Cycle 2019;18:3300-12. [PMID: 31594449 DOI: 10.1080/15384101.2019.1674053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Yu J, Wang L, Zhang T, Shen H, Dong W, Ni Y, Du J. Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma. Tumour Biol 2015;36:6551-8. [PMID: 25820700 DOI: 10.1007/s13277-015-3349-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
6 Ma N, Si L, Yang M, Li M, He Z. A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation. Sci Rep 2021;11:5855. [PMID: 33712694 DOI: 10.1038/s41598-021-85246-x] [Reference Citation Analysis]
7 Incoronato M, Aiello M, Infante T, Cavaliere C, Grimaldi AM, Mirabelli P, Monti S, Salvatore M. Radiogenomic Analysis of Oncological Data: A Technical Survey. Int J Mol Sci 2017;18:E805. [PMID: 28417933 DOI: 10.3390/ijms18040805] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 11.2] [Reference Citation Analysis]
8 Goyen M. Radiogenomic imaging-linking diagnostic imaging and molecular diagnostics. World J Radiol 2014; 6(8): 519-522 [PMID: 25170389 DOI: 10.4329/wjr.v6.i8.519] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sollini M, Bartoli F, Marciano A, Zanca R, Slart RHJA, Erba PA. Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology. Eur J Hybrid Imaging 2020;4:24. [PMID: 34191197 DOI: 10.1186/s41824-020-00094-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lin G, Li C, Huang C, Zhuang W, Huang Y, Xu H, Miao Q, Hu D. Co-expression of NF-κB-p65 and phosphorylated NF-κB-p105 is associated with poor prognosis in surgically resectable non-small cell lung cancer. J Cell Mol Med 2018;22:1923-30. [PMID: 29363879 DOI: 10.1111/jcmm.13476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Vardhanabhuti V, Kuo MD. Lung Cancer Radiogenomics: The Increasing Value of Imaging in Personalized Management of Lung Cancer Patients. J Thorac Imaging 2018;33:17-25. [PMID: 29252899 DOI: 10.1097/RTI.0000000000000312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Jin Y, Chen J, Feng Z, Fan W, Wang Y, Li J, Tong D. The expression of Survivin and NF-κB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma. Tumor Biol 2014;35:9905-10. [DOI: 10.1007/s13277-014-2279-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
13 Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ. The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor. Brain Pathol 2016;26:3-17. [PMID: 26269128 DOI: 10.1111/bpa.12299] [Cited by in Crossref: 197] [Cited by in F6Publishing: 182] [Article Influence: 28.1] [Reference Citation Analysis]
14 Cook GJR, Goh V. A Role for FDG PET Radiomics in Personalized Medicine? Semin Nucl Med 2020;50:532-40. [PMID: 33059822 DOI: 10.1053/j.semnuclmed.2020.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
15 Zukotynski KA, Hasan OK, Lubanovic M, Gerbaudo VH. Update on Molecular Imaging and Precision Medicine in Lung Cancer. Radiol Clin North Am 2021;59:693-703. [PMID: 34392913 DOI: 10.1016/j.rcl.2021.05.002] [Reference Citation Analysis]
16 Plodkowski AJ, Drilon A, Halpenny DF, O'Driscoll D, Blair D, Litvak AM, Zheng J, Moskowitz CS, Ginsberg MS. From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements? Lung Cancer. 2015;90:321-325. [PMID: 26424208 DOI: 10.1016/j.lungcan.2015.09.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ciribilli Y, Singh P, Inga A, Borlak J. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma. Oncotarget 2016;7:65514-39. [PMID: 27602772 DOI: 10.18632/oncotarget.11804] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
18 Chung YH, Yu CF, Chiu SC, Chiu H, Hsu ST, Wu CR, Yang CL, Hong JH, Yen TC, Chen FH. Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. Eur J Nucl Med Mol Imaging 2019;46:1733-44. [PMID: 31127350 DOI: 10.1007/s00259-019-04318-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zukotynski KA, Gerbaudo VH. Molecular Imaging and Precision Medicine in Lung Cancer. PET Clin 2017;12:53-62. [PMID: 27863566 DOI: 10.1016/j.cpet.2016.08.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
20 Yip SS, Aerts HJ. Applications and limitations of radiomics. Phys Med Biol. 2016;61:R150-R166. [PMID: 27269645 DOI: 10.1088/0031-9155/61/13/r150] [Cited by in Crossref: 397] [Cited by in F6Publishing: 223] [Article Influence: 66.2] [Reference Citation Analysis]
21 Yang B, Guo L, Lu G, Shan W, Duan L, Duan S. Radiomic signature: a non-invasive biomarker for discriminating invasive and non-invasive cases of lung adenocarcinoma. Cancer Manag Res 2019;11:7825-34. [PMID: 31695487 DOI: 10.2147/CMAR.S217887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Yang B, Ji HS, Zhou CS, Dong H, Ma L, Ge YQ, Zhu CH, Tian JH, Zhang LJ, Zhu H, Lu GM. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinoma. Transl Lung Cancer Res 2020;9:563-74. [PMID: 32676320 DOI: 10.21037/tlcr-19-592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Wu D, Wu P, Zhao L, Huang L, Zhang Z, Zhao S, Huang J. NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2015;94:e1687. [PMID: 26448015 DOI: 10.1097/MD.0000000000001687] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 9.3] [Reference Citation Analysis]
24 Nougaret S, Vargas HA, Horta M, Lakhman Y, Sala E. Ovarian Cancer from Anatomy to Functional Imaging. Curr Radiol Rep 2015;3. [DOI: 10.1007/s40134-015-0125-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Lovinfosse P, Hatt M, Visvikis D, Hustinx R. Heterogeneity analysis of 18F-FDG PET imaging in oncology: clinical indications and perspectives. Clin Transl Imaging 2018;6:393-410. [DOI: 10.1007/s40336-018-0299-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
26 European Society of Radiology (ESR). Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR). Insights Imaging 2015;6:141-55. [PMID: 25763994 DOI: 10.1007/s13244-015-0394-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
27 Li X, Zhu M, Brasier AR, Kudlicki AS. Inferring genome-wide functional modulatory network: a case study on NF-κB/RelA transcription factor. J Comput Biol 2015;22:300-12. [PMID: 25844669 DOI: 10.1089/cmb.2014.0299] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
28 Grimm LJ. Breast MRI radiogenomics: Current status and research implications. J Magn Reson Imaging 2016;43:1269-78. [PMID: 26663695 DOI: 10.1002/jmri.25116] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
29 Gu L, Wang Z, Zuo J, Li H, Zha L. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis. PLoS One 2018;13:e0198223. [PMID: 29813121 DOI: 10.1371/journal.pone.0198223] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
30 Ouyang X, Huang Y, Jin X, Zhao W, Hu T, Wu F, Huang J. Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer. Onco Targets Ther 2018;11:5933-41. [PMID: 30275702 DOI: 10.2147/OTT.S164007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
31 Shui L, Ren H, Yang X, Li J, Chen Z, Yi C, Zhu H, Shui P. The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology. Front Oncol 2020;10:570465. [PMID: 33575207 DOI: 10.3389/fonc.2020.570465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, Ayers K, Bakr S, Gentles AJ, Diehn M, Quon A, West RB, Nair V, van de Rijn M, Napel S, Plevritis SK. GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma. Cancer Res 2018;78:3445-57. [PMID: 29760045 DOI: 10.1158/0008-5472.CAN-17-2928] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
33 Cook GJR, Goh V. What can artificial intelligence teach us about the molecular mechanisms underlying disease? Eur J Nucl Med Mol Imaging 2019;46:2715-21. [PMID: 31190176 DOI: 10.1007/s00259-019-04370-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
34 Choi J, Gim JA, Oh C, Ha S, Lee H, Choi H, Im HJ. Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis. EJNMMI Res 2019;9:97. [PMID: 31754877 DOI: 10.1186/s13550-019-0563-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
35 Heiden BT, Chen G, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM. 18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer. PLoS One 2018;13:e0199970. [PMID: 29966011 DOI: 10.1371/journal.pone.0199970] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
36 Yang J, Yuan D, Li J, Zheng S, Wang B. miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition. Tumor Biol 2016;37:4331-41. [DOI: 10.1007/s13277-015-4117-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
37 Moon SH, Kim J, Joung J, Cha H, Park W, Ahn JS, Ahn M, Park K, Choi JY, Lee K, Kim B, Lee S. Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer. Eur J Nucl Med Mol Imaging 2019;46:446-54. [DOI: 10.1007/s00259-018-4138-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
38 Heiden BT, Patel N, Nancarrow DJ, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM. Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma. J Surg Res 2018;232:621-8. [PMID: 30463782 DOI: 10.1016/j.jss.2018.06.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
39 Yao F, Zhou W, Zhong C, Fang W. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ. Tumour Biol 2015;36:7873-9. [PMID: 25946971 DOI: 10.1007/s13277-015-3362-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
40 Lee G, Lee HY, Ko ES, Jeong WK. Radiomics and imaging genomics in precision medicine. Precis Future Med 2017;1:10-31. [DOI: 10.23838/pfm.2017.00101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
41 Hoshino I, Yokota H, Iwatate Y, Mori Y, Kuwayama N, Ishige F, Itami M, Uno T, Nakamura Y, Tatsumi Y, Shimozato O, Nagase H. Prediction of the differences in tumor mutation burden between primary and metastatic lesions by radiogenomics. Cancer Sci 2021. [PMID: 34689378 DOI: 10.1111/cas.15173] [Reference Citation Analysis]
42 Halpenny DF, Plodkowski A, Riely G, Zheng J, Litvak A, Moscowitz C, Ginsberg MS. Radiogenomic evaluation of lung cancer - Are there imaging characteristics associated with lung adenocarcinomas harboring BRAF mutations? Clin Imaging. 2017;42:147-151. [PMID: 28012356 DOI: 10.1016/j.clinimag.2016.11.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
43 Jansen RW, van Amstel P, Martens RM, Kooi IE, Wesseling P, de Langen AJ, Menke-Van der Houven van Oordt CW, Jansen BHE, Moll AC, Dorsman JC, Castelijns JA, de Graaf P, de Jong MC. Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis. Oncotarget 2018;9:20134-55. [PMID: 29732009 DOI: 10.18632/oncotarget.24893] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]